Historical Stock Price
ETFs Holding AEZS »    AEZS Split History »
Video: Compound Annual Growth Rate (CAGR) Definition


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Date Open High Low Close Volume
05/20/2022 $0.20 $0.21 $0.19 $0.20 489.60K
05/23/2022 $0.21 $0.22 $0.21 $0.21 687.70K
05/24/2022 $0.22 $0.22 $0.19 $0.20 493.60K
05/25/2022 $0.21 $0.21 $0.20 $0.21 416.90K
05/26/2022 $0.20 $0.21 $0.20 $0.21 235.00K
Aeterna Zentaris is a holding company. Through its subsidiaries, Co. is a biopharmaceutical company commercializing and developing therapeutics and diagnostic tests. Co.'s primary product, macimorelin, is an oral test indicated for the diagnosis of patients with adult growth hormone deficiency. Macimorelin is marketed in the U.S. under the tradename Macrilen™ through a license agreement with Novo Nordisk.
AEZS historical stock prices picture
AEterna Zentaris (AEZS) has the following price history information. Looking back at AEZS historical stock prices for the last five trading days, on May 20, 2022, AEZS opened at $0.20, traded as high as $0.21 and as low as $0.19, and closed at $0.20. Trading volume was a total of 489.60K shares. On May 23, 2022, AEZS opened at $0.21, traded as high as $0.22 and as low as $0.21, and closed at $0.21. Trading volume was a total of 687.70K shares. On May 24, 2022, AEZS opened at $0.22, traded as high as $0.22 and as low as $0.19, and closed at $0.20. Trading volume was a total of 493.60K shares. On May 25, 2022, AEZS opened at $0.21, traded as high as $0.21 and as low as $0.20, and closed at $0.21. Trading volume was a total of 416.90K shares. On May 26, 2022, AEZS opened at $0.20, traded as high as $0.21 and as low as $0.20, and closed at $0.21. Trading volume was a total of 235.00K shares.

AEZS Historical Stock Prices By Date:

AEZS historical cagr picture

Below, we examine the compound annual growth rate — CAGR for short — of an investment into AEterna Zentaris shares, starting with a $10,000 purchase of AEZS, and working forward through the historical stock price information to today.

Growth of $10,000.00
Without Dividends Reinvested

Start date: 05/30/2012
End date: 05/26/2022
Start price/share: $258.00
End price/share: $0.21
Dividends collected/share: $0.00
Total return: -99.92%
Average Annual Total Return: -50.92%
Starting investment: $10,000.00
Ending investment: $8.14
Years: 9.99
Date Close
05/20/2022$0.20
05/23/2022$0.21
05/24/2022$0.20
05/25/2022$0.21
05/26/2022$0.21
AEZS is categorized under the Healthcare sector; below are some other companies in the same sector:

AFAM Historical Stock Prices
AFFX Historical Stock Prices
AGEN Historical Stock Prices
AGIO Historical Stock Prices
AGLE Historical Stock Prices
AGN Historical Stock Prices
AGRX Historical Stock Prices
AGTC Historical Stock Prices
AHPI Historical Stock Prices
AHS Historical Stock Prices

Also explore: AEZS shares outstanding history

Email EnvelopeFree AEZS Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

AEZS Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2022, All Rights Reserved

Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.